2007 Published articles:
Barr IG, Hurt AC, Iannello P, Tomasov C, Deed N, Komadina N. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral Research 2007 Feb;73(2):112-7. Pubmed link
Hurt AC, Selleck P, Komadina K, Shaw R, Barr IG. Susceptibility of highly pathogenic H5N1 avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Research. 2007 Mar;73(3):228-31. Pubmed link
Komadina N, Roque VG, Thawatsupha P, Rimando-Magalong J, Waicharoen S, Bomasang
ES, Sawanpanyalert P, Rivera MO, Iannello P, Hurt AC, Barr IG. Genetic analysis
of two A(H1) swine influenza viruses that have infected humans in Thailand and
the Philippines. Virus Genes2007 Apr 11; [Epub ahead of print]
Pubmed
link
Li OTW, Barr I, Leung CYH, Chen H, Guan Y, Peiris JSM, Poon LLM. Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences form all 16 haemaggluntinin subtypes. J. Virol. Meth. 2007 Jun;142(1-2):218-22. Pubmed link
Jayawardena S, Cheung CY, Barr I, Chen H, Guan Y, Peiris MJS, Poon LLM. Detection of H5N1 by reverse transcription loop-mediated isothermal amplification. Emerg. Infect. Dis. In press.
Barr IG, Hurt AC, Deed N, Iannello P, Tomasov C, Komadina N. The emergence of Adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006. Antiviral Research.2007 Aug;75(2):173-6. Epub 2007 Feb 15. Pubmed link
Hurt A, Alexander R, Hibbert J. Deed N, Barr I. Performance of six influenza
rapid tests in detecting human influenza in clinical trials. J. Clin. Virol.
2007 Apr 21; [Epub ahead of print] Pubmed
link
2006 Published articles:
Ayob AE, Selviendran N, Hampson AW, Barr, IG, Selvaraja AL, Chua KB. Outbreak of Influenza amongst Residential School Students in Malaysia. Med. J. Malalysia. 2006 61: 168-72. Pubmed link
Hurt AC, Iannello P, Jachno, Komadina N, Hampson AW, Barr IG, McKimm-Breschkin JL. Naturally occurring neuraminidase inhibitor resistant and sensitive influenza B viruses in a human clinical sample. Antiviral Research. 2006 50(5):1872-4.
Cook IF, Barr IG, Hartel G, Pond D, Hampson AW. Reactogenticity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine 2006 24(13):2395-402 Pubmed link
Ng LFP, Barr I, Nguyen T, Noor SM, Tan RSP, Agathe LV, Gupta S, Khalil H, To TL, Hassan, Ren EC. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infectious Diseases 2006, 6:40. Pubmed link
Barr IG, McCaig M, Durrant C, Shaw R. The rapid identification of influenza neuraminidase N1 and N2 subtypes by ELISA. Vaccine 2006 Nov 10;24(44-46):6675-8.. Pubmed link
Haaheim LR, Tomasov CC, Barr IG, Hampson AW, Komadina N. Identification of genetic diversity by cultivating influenza A(H3N2) virus in vitro in the presence of post-infection sera from small children. Vaccine. 2006 Nov 10;24(44-46):6708-11. Epub 2006 Jun 12 . Pubmed link
Hurt AC, Hansbro PM, Selleck P, Olsen B, Minton C, Hampson AW, Barr IG. Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia. Arch. Virol. 2006 Nov;151(11):2301-9. Pubmed link
Barr I.G, Komadina N, Durrant C, Sjogren H, Hurt, A, Shaw R.P. Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000. Comm. Dis. Intell. 2006;30(3):350-7. Pubmed link
Firestone S, Roche P, Barr IG, Walker JC. Annual report of the National Influenza Surveillance Scheme, 2005. Comm. Dis. Intell. 2006;30:189-200. Pubmed link
Hurt A, Barr I. Rapid diagnostic test kits for influenza. Microbiology Australia. May 1 2006.
Hurt AC, Ho HT,
Barr IG. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Expert Review of Anti-infective Therapy. 2006, Vol. 4, No. 5, Pages 795-805.
Pubmed
link
Dwyer DE, Smith
D, Caton M, Barr I. Laboratory diagnosis of human seasonal and pandemic influenza
virus infection. Med. J. Aust.2006 Nov 20;185(10 Suppl):S48-53. Pubmed
link
2005 Published articles:
Alexander
R, Hurt AC, Lamb D, Wong FY, Hampson AW, Barr IG. A comparison of a rapid test
for influenza with laboratory-based diagnosis in a paediatric population.
Commun Dis Intell. 2005;29(3):272-6. Pubmed
link
Barr IG, Komadina N, Hurt AC, Iannello P, Tomasov C, Shaw R, Durrant C, Sjogren
H, Hampson AW. An influenza A(H3) reassortant was epidemic in Australia and
New Zealand in 2003. J Medical Virology. 2005;76:391-7. Pubmed
link
Berlioz-Arthaud
A, Barr IG. Laboratory-based influenza surveillance in New Caledonia, 1999-2003.
Trans R Soc Trop Med Hyg. 2005 Apr;99(4):290-300. Pubmed
link
Hayden
F, Klimov A, Tashiro M, Hay A, Monto A, McKimm-Breschkin J, Macken C, Hampson
A, Webster RG, Amyard M, Zambon M. Neuraminidase inhibitor susceptibility network
position statement: antiviral resistance in influenza A/H5N1 viruses. Antivir
Ther. 2005;10(8):873-7. Pubmed
link
Li
J, Hampson A, Roche PW, Yohannes K, Spencer JD. Annual report of the National
Influenza Surveillance Scheme, 2004. Commun Dis Intell. 2005;29(2):125-36. Pubmed
link
WHO
Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza
viruses in Asia. Emerg Infect Dis. 2005 Oct;11(10):151-21.Pubmed
link
2004 Published articles:
Cheam AL, Barr IG, Hampson AW, Mosse J, Hurt AC.In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors. Antiviral Res. 2004 Sep;63(3):177-81. Pubmed link
Hurt A.C., Barr I.G., Durrant C.J., Shaw R.P., Sjogren H.M., Hampson A.W. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. Communicable Disease Intelligence 2003;27:542-547. Pubmed link
Hurt AC, Barr IG, Hartel G, Hampson AW. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res. 2004. 62, 37-45. Pubmed link
Hurt AC, Barr IG, Komadina N, Hampson AW. A novel means of identifying the neuraminidase types of currently circulating human A(H1) influenza viruses. Virus Res. 2004. 103; 79-83. Pubmed link
Hurt AC, McKimm-Breschkin JL, McDonald M, Barr IG, Komadina N, Hampson AW. Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs. Virus Res. 2004. 103; 205-11. Pubmed link
Yohannes K., Roche P., Hampson A., Miller M., Spencer J. Annual report of the National Influenza Surveillance Scheme, 2003. Communicable Disease Intelligence 2004;28:160-168. Pubmed link
2003 Published articles:
Barr
IG, Komadina N, Hurt A, Shaw R, Durrant C, Iannello P, Tomasov C, Sjogren H,
Hampson A. Reassortants in recent human influenza A and B isolates from South
East Asia and Oceania. Virus Research 98 (1):35-44, 2003. Pubmed
link
Cohen P, Darling C, Hampson A, Downs K, Tasset-Tisseau A. Influenza vaccination in an occupational setting: effectiveness and cost-benefit study. J.Occup.Health Safety 19 (2):167-182, 2003.
Hurt A, Barr I, Durrant C, Shaw R, Sjogren H, Hampson A. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. Commun.Dis.Intell. 27(4):542-547, 2003. Pubmed link
McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F, Zambon M. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob.Agents Chemother. 47 (7):2264-2272, 2003. Pubmed link
Nguyen-Van-Tam JS, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine 21 (16):1762-1768, 2003. Pubmed link
Yohannes K, Roche P, Spencer J, Hampson A. Annual report of the National Influenza Surveillance Scheme, 2002. Commun.Dis.Intell. 27 (2):162-172, 2003. Pubmed link